Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$3.07 - $10.25 $82 - $276
-27 Reduced 39.71%
41 $0
Q3 2023

May 20, 2024

SELL
$10.52 - $20.68 $736 - $1,447
-70 Reduced 50.72%
68 $0
Q3 2023

Nov 13, 2023

SELL
$10.52 - $20.68 $736 - $1,447
-70 Reduced 50.72%
68 $0
Q1 2023

May 20, 2024

BUY
$18.25 - $30.26 $1,770 - $2,935
97 Added 236.59%
138 $2,000
Q1 2023

Apr 25, 2023

SELL
$18.25 - $30.26 $912 - $1,513
-50 Reduced 26.6%
138 $2,000
Q4 2022

Feb 03, 2023

BUY
$12.36 - $26.41 $2,323 - $4,965
188 New
188 $4,000
Q2 2022

Aug 01, 2022

SELL
$13.46 - $48.16 $457 - $1,637
-34 Closed
0 $0
Q1 2022

Apr 28, 2022

BUY
$34.22 - $47.24 $1,163 - $1,606
34 New
34 $2,000
Q4 2021

Jan 20, 2022

SELL
$43.29 - $58.77 $4,069 - $5,524
-94 Closed
0 $0
Q3 2021

Nov 02, 2021

BUY
$36.86 - $54.98 $3,464 - $5,168
94 New
94 $5,000

Others Institutions Holding OM

About Outset Medical, Inc.


  • Ticker OM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 48,007,300
  • Market Cap $42.2M
  • Description
  • Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...
More about OM
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.